The paper ‘Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway’ co-authored by Quantify’s Fredrik Borgström, Amanda Hansson-Hedblom and Isabelle Axelsson, has been published in the Journal of […]
Do you have experience in market access, RWE, and project leading? Do you want to work in an exciting international environment at a growing HEOR consultancy? Are you a team player with an analytical mindset and a proven track record? […]
Quantify is pleased to announce the appointment of Kirk Geale as the new CEO of Quantify Research, replacing Åsa By after 7 highly successful years. Quantify is grateful to Åsa for the visionary leadership and energy she brought to the […]
The winter holidays are a time of giving. Healthcare after a natural disaster for example. Therefore, Quantify has made a donation to Médecins Sans Frontières (MSF), supporting their lifesaving work. Our Christmas gift is enough to […]
You will find us at exhibitor booth #C2-024. Stop by to learn more about Quantify’s work with visualisations, generic models, webapp Qfront and the latest developments in Nordic RWE. Or just have […]
Yesterday we shared our expertise in health technology assessment in Sweden with LIF and industry colleagues. Interested in learning about market access, HTA, or health economics? Drop us a line at info@quantifyresearch.com or +46 707 36 55 69!
[…]
Quantify just kicked off the autumn season out in the beautiful Stockholm archipelago, with team building activities such as kayaking, best practice seminars and relaxing in the spa. Having returned […]
The poster ‘Impact of Early Statin Titration on Subsequent Cardiovascular Events: Estimates from Swedish Population-Based Registry Data’, co-authored by Maria Lindh and Jonas Banefelt of Quantify, will be presented in a moderated poster session at […]
